Gilead Sciences GILD
NASDAQ GILD
$146.83 +3.39 (+2.36%)
As of: Aug 21, 2026 · 1:31 PM EDT

Gilead Sciences (GILD) Net Margin (QoQ) (2009 - 2026)

Gilead Sciences (GILD) Net Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 651.33 Bn 630.58 Bn 17.26 Bn
2 AbbVie 469.67 Bn 463.10 Bn 12.70 Bn
3 Merck 374.13 Bn 366.99 Bn 12.21 Bn
4 Novartis Ag 302.76 Bn 295.07 Bn 11.24 Bn
5 Astrazeneca 257.15 Bn 252.25 Bn 12.86 Bn
6 Amgen 236.76 Bn 222.77 Bn 7.24 Bn
7 Gilead Sciences 182.54 Bn 179.36 Bn 6.22 Bn
8 Pfizer 159.57 Bn 147.87 Bn 10.94 Bn
9 Gsk 105.99 Bn 101.83 Bn 8.24 Bn
10 Sanofi 55.15 Bn 47.77 Bn 10.79 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 -16,355.00
Mar 31, 2026 -286.00
Dec 31, 2025 -739.00
Sep 30, 2025 1,159.00
Jun 30, 2025 797.00
Mar 31, 2025 -382.00
Dec 31, 2024 694.00
Sep 30, 2024 -662.00
Jun 30, 2024 8,561.00
Mar 31, 2024 -8,229.00
Dec 31, 2023 -1,090.00
Sep 30, 2023 1,506.00
Jun 30, 2023 25.00
Mar 31, 2023 -661.00
Dec 31, 2022 -326.00
Sep 30, 2022 723.00
Jun 30, 2022 1,795.00
Mar 31, 2022 -501.00
Dec 31, 2021 -2,966.00
Sep 30, 2021 1,045.00